Multi-site screening for Pneumocystis jirovecii in lung cancer: possible tumour tissue colonization

Magdalena Szydłowicz1, Żaneta Zajączkowska1, Mariusz Chabowski2,3

  • 1Department of Biology and Medical Parasitology, Wroclaw Medical University, Wroclaw, Poland.

Abstract

Insights

The opportunistic fungus Pneumocystis jirovecii can be found in lung cancer tissues. This discovery suggests potential links between the lung microbiome and cancer development, opening avenues for new diagnostic approaches.

Area of Science:

  • Medical Mycology
  • Oncology
  • Microbiome Research

Background:

  • Emerging evidence indicates various microorganisms colonize diverse tumor types.
  • Data on the opportunistic fungus Pneumocystis jirovecii (PJP) in cancer, particularly lung cancer, is limited.
  • PJP is known to distribute focally within the lungs, posing a diagnostic challenge.

Purpose of the Study:

  • To investigate the presence and distribution of PJP in lung tumor tissues.
  • To explore the potential colonization of neoplastic lung tissue by PJP.
  • To assess the relationship between PJP detection and lung cancer characteristics.

Main Methods:

  • Collection of neoplastic tissue (NPL), normal adjacent tissue (NAT), and respiratory secretions (RS) from 70 lung cancer patients.
  • DNA extraction and nested-PCR analysis targeting mtLSU rRNA and CYB loci for PJP detection.
  • Genotyping of detected PJP strains to analyze distribution patterns.

Main Results:

  • PJP was detected in 11.4% (8/70) of individuals across NPL, NAT, and RS samples.
  • PJP was found in 2 neoplastic tissue samples.
  • In two patients with high-grade malignancy (G3), PJP was detected in all three specimen types, with varying genotype distributions.

Conclusions:

  • Pneumocystis jirovecii can colonize neoplastic lung tissue, potentially influenced by tumor advancement and microenvironment.
  • Findings highlight the significance of the lung microbiome in tumor-associated microenvironments.
  • Further research into the lung microbiome may offer complementary biomarkers for lung cancer diagnosis and management.